Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series
Objectives: The prognosis for metastatic cervical cancer has dramatically improved in the past years with the addition of anti-PD1/PD-L1 immunotherapy to standard platinum-based chemotherapy +/-bevacizumab. Here, we aimed to investigate the benefit from combining chemo-immuno-radiotherapy for metast...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2025-10-01
|
| Serija: | Gynecologic Oncology Reports |
| Teme: | |
| Online pristup: | http://www.sciencedirect.com/science/article/pii/S2352578925002929 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|